Cargando…

A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is a complex disease and is comprised of several histological subtypes, the most frequent of which are clear cell renal cell carcinoma (ccRCC), papillary renal cell carcinoma (PRCC) and chromophobe renal cell carcinoma (ChRCC). While lots of studies have been p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Xiaohui, Liu, Yusong, Yu, Christina Y., Wang, Tian-Fu, Zhang, Jie, Ni, Dong, Huang, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771093/ https://www.ncbi.nlm.nih.gov/pubmed/33371886 http://dx.doi.org/10.1186/s12920-020-00827-5

Ejemplares similares

Sample-specific perturbation of gene interactions identifies breast cancer subtypes
por: Chen, Yuanyuan, et al.
Publicado: (2020)

Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes
por: Wei, Ran, et al.
Publicado: (2022)

A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
por: Chen, Peikai, et al.
Publicado: (2013)

DIPG-35. IDENTIFYING DRIVER-SPECIFIC VULNERABILITIES IN PAEDIATRIC HIGH GRADE GLIOMA SUBTYPES
por: De Cola, Antonella, et al.
Publicado: (2023)

Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining
por: Zhan, Xiaohui, et al.
Publicado: (2023)

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
por: Luo, Zhenhua, et al.
Publicado: (2019)

Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
por: Cava, Claudia, et al.
Publicado: (2018)

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018)

Pan‐Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival
por: Sousa, Abel, et al.
Publicado: (2023)

Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment
por: Xu, Hui, et al.
Publicado: (2023)

Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis
por: Wang, Gaojianyong, et al.
Publicado: (2020)

Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
por: Rodriguez-Martin, Bernardo, et al.
Publicado: (2020)

Development of a pan-neuronal genetic driver in Aedes aegypti mosquitoes
por: Zhao, Zhilei, et al.
Publicado: (2021)

The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes
por: Lu, Xinguo, et al.
Publicado: (2018)

Non-Perturbative Identification and Subtyping of Amyloidosis in Human Kidney Tissue with Raman Spectroscopy and Machine Learning
por: Kim, Jeong Hee, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer
por: Gatza, Michael L., et al.
Publicado: (2014)

Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
por: Rodriguez-Martin, Bernardo, et al.
Publicado: (2023)

Identifying Drivers of Poor Kidney Transplant Outcomes in Indigenous Populations
por: Hall, Isaac E., et al.
Publicado: (2022)

Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes
por: Li, Canrong, et al.
Publicado: (2022)

Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
por: Ning, Yumei, et al.
Publicado: (2023)

Pan-cancer detection of driver genes at the single-patient resolution
por: Nulsen, Joel, et al.
Publicado: (2021)

Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS
por: Morello, Giovanna, et al.
Publicado: (2019)

Stabilized COre gene and Pathway Election uncovers pan-cancer shared pathways and a cancer-specific driver
por: Kossinna, Pathum, et al.
Publicado: (2022)

A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces
por: Porta-Pardo, Eduard, et al.
Publicado: (2015)

Identification of driver modules in pan-cancer via coordinating coverage and exclusivity
por: Gao, Bo, et al.
Publicado: (2017)

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
por: Brady, Samuel W., et al.
Publicado: (2020)

Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
por: Korenjak, Michael, et al.
Publicado: (2019)

LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
por: Song, Yang, et al.
Publicado: (2021)

Drivers of Dyadic Cofeeding Tolerance in Pan: A Composite Measure Approach
por: Staes, Nicky, et al.
Publicado: (2022)

Pan-cancer clinical impact of latent drivers from double mutations
por: Yavuz, Bengi Ruken, et al.
Publicado: (2023)

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer
por: Silva, Grace O., et al.
Publicado: (2015)

Pan-urologic cancer genomic subtypes that transcend tissue of origin
por: Chen, Fengju, et al.
Publicado: (2017)

Identifying Network Perturbation in Cancer
por: Grechkin, Maxim, et al.
Publicado: (2016)

Pan-cancer subtyping in a 2D-map shows substructures that are driven by specific combinations of molecular characteristics
por: Taskesen, Erdogan, et al.
Publicado: (2016)

Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators
por: Simeone, Ines, et al.
Publicado: (2023)

Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes
por: Zou, Haozhe, et al.
Publicado: (2022)

Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
por: Srivatsa, Sumana, et al.
Publicado: (2022)

Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach
por: Zhang, Di, et al.
Publicado: (2015)

Identifying heterogeneous subtypes of gastric cancer and subtype-specific subpaths of microRNA-target pathways
por: Li, Yuanhang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_trqjua9bjgha1cg1tfojh1rmeo